BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 37933684)

  • 21. Angioimmunoblastic T-cell lymphoma contains multiple clonal T-cell populations derived from a common TET2 mutant progenitor cell.
    Yao WQ; Wu F; Zhang W; Chuang SS; Thompson JS; Chen Z; Zhang SW; Clipson A; Wang M; Liu H; Bibawi H; Huang Y; Campos L; Grant JW; Wright P; Ei-Daly H; Rásó-Barnett L; Farkas L; Follows GA; Gao Z; Attygalle AD; Ashton-Key M; Liu W; Du MQ
    J Pathol; 2020 Mar; 250(3):346-357. PubMed ID: 31859368
    [TBL] [Abstract][Full Text] [Related]  

  • 22. T-cell receptor gene rearrangement analysis: cutaneous T cell lymphoma, peripheral T cell lymphoma, and premalignant and benign cutaneous lymphoproliferative disorders.
    Zelickson BD; Peters MS; Muller SA; Thibodeau SN; Lust JA; Quam LM; Pittelkow MR
    J Am Acad Dermatol; 1991 Nov; 25(5 Pt 1):787-96. PubMed ID: 1839392
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Clinical Spectrum of Primary Cutaneous CD4+ Small/Medium-Sized Pleomorphic T-Cell Lymphoproliferative Disorder: An Updated Systematic Literature Review and Case Series.
    Surmanowicz P; Doherty S; Sivanand A; Parvinnejad N; Deschenes J; Schneider M; Hardin J; Gniadecki R
    Dermatology; 2021; 237(4):618-628. PubMed ID: 33326960
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of T-follicular helper markers in sequential biopsies of progressive mycosis fungoides and other primary cutaneous T-cell lymphomas.
    Bosisio FM; Cerroni L
    Am J Dermatopathol; 2015 Feb; 37(2):115-21. PubMed ID: 25406852
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Primary cutaneous CD4-positive small/medium-sized pleomorphic T-cell lymphoma: a clonal T-cell lymphoproliferative disorder with indolent behavior.
    Grogg KL; Jung S; Erickson LA; McClure RF; Dogan A
    Mod Pathol; 2008 Jun; 21(6):708-15. PubMed ID: 18311111
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Primary Cutaneous CD4+ Small/Medium T-Cell Lymphoproliferative Disorder or Primary Cutaneous Marginal Zone B-Cell Lymphoma? Two Distinct Entities With Overlapping Histopathological Features.
    Bakr F; Wain EM; Barlow R; Robson A
    Am J Dermatopathol; 2021 Dec; 43(12):e204-e212. PubMed ID: 34231494
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Specificity of IRF4 translocations for primary cutaneous anaplastic large cell lymphoma: a multicenter study of 204 skin biopsies.
    Wada DA; Law ME; Hsi ED; Dicaudo DJ; Ma L; Lim MS; Souza Ad; Comfere NI; Weenig RH; Macon WR; Erickson LA; Ozsan N; Ansell SM; Dogan A; Feldman AL
    Mod Pathol; 2011 Apr; 24(4):596-605. PubMed ID: 21169992
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinicopathologic and microenvironmental analysis of primary cutaneous CD30-positive lymphoproliferative disorders: a 26 year experience from an academic medical center in Brazil.
    Ferreira CR; Zhao S; Sanches JA; Miyashiro D; Cury-Martins J; Azevedo RS; Zerbini MCN; Natkunam Y; Gratzinger D
    Diagn Pathol; 2019 Oct; 14(1):115. PubMed ID: 31640798
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reappraisal of the provisional entity primary cutaneous CD4+ small/medium pleomorphic T-cell lymphoma: a series of 10 adult and pediatric patients and review of the literature.
    Baum CL; Link BK; Neppalli VT; Swick BL; Liu V
    J Am Acad Dermatol; 2011 Oct; 65(4):739-748. PubMed ID: 21641676
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Case for diagnosis. Primary cutaneous CD4+ small/medium T-cell lymphoproliferative disorder.
    Valentim FO; Oliveira CC; Miot HA
    An Bras Dermatol; 2019; 94(1):99-101. PubMed ID: 30726474
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Primary cutaneous lymphoproliferative disorders with dual lineage rearrangement.
    Kazakov DV; Kutzner H; Palmedo G; Boudova L; Michaelis S; Michal M; Vanecek T; Magro CM; Mukensnabl P; Dummer R; Burg G; Kempf W
    Am J Dermatopathol; 2006 Oct; 28(5):399-409. PubMed ID: 17012914
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Deciphering the spectrum of cutaneous lymphomas expressing TFH markers.
    Donzel M; Trecourt A; Balme B; Harou O; Mauduit C; Bachy E; Guesquières H; Fontaine J; Ortonne N; Perier-Muzet M; Dalle S; Traverse-Glehen A
    Sci Rep; 2023 Apr; 13(1):6500. PubMed ID: 37081015
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The spectrum of CD30+ T cell lymphoproliferative disorders in the skin.
    Kartan S; Johnson WT; Sokol K; Alpdogan O; Gru AA; Nikbakht N; Porcu P
    Chin Clin Oncol; 2019 Feb; 8(1):3. PubMed ID: 30691273
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multifocal CD4+ Primary Cutaneous Small/Medium Lymphoproliferative Disorder Successfully Treated With Low-Dose Oral Methotrexate: A Case Report.
    Dimassi AB; Howlett C; Phua CW
    Cureus; 2020 Jun; 12(6):e8534. PubMed ID: 32665881
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Surgical, Dermatological and Morphopathological Considerations in the Diagnosis and Treatment of Cutaneous Lymphoproliferative Tumors, Primary CD4.
    Ardeleanu V; Moroianu LA; Sava A; Tebeica T; Jecan RC; Moroianu M; Tatu AL
    Medicina (Kaunas); 2022 Nov; 58(11):. PubMed ID: 36363575
    [TBL] [Abstract][Full Text] [Related]  

  • 36. New developments in non-Hodgkin lymphoid malignancies.
    Ganapathi KA; Brown LE; Prakash S; Bhargava P
    Pathology; 2021 Apr; 53(3):349-366. PubMed ID: 33685720
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Primary cutaneous CD4+ small/medium pleomorphic T-cell lymphoproliferative disorder: Where do we stand? A systematic review.
    Salah E
    J Dtsch Dermatol Ges; 2019 Feb; 17(2):123-136. PubMed ID: 30506921
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CD70 expression correlates with a worse prognosis in malignant pleural mesothelioma patients via immune evasion and enhanced invasiveness.
    Inaguma S; Lasota J; Czapiewski P; Langfort R; Rys J; Szpor J; Waloszczyk P; Okoń K; Biernat W; Schrump DS; Hassan R; Kasai K; Miettinen M; Ikeda H
    J Pathol; 2020 Feb; 250(2):205-216. PubMed ID: 31639216
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Primary cutaneous CD4+ small/medium-sized pleomorphic T-cell lymphoma expresses follicular T-cell markers.
    Rodríguez Pinilla SM; Roncador G; Rodríguez-Peralto JL; Mollejo M; García JF; Montes-Moreno S; Camacho FI; Ortiz P; Limeres-González MA; Torres A; Campo E; Navarro-Conde P; Piris MA
    Am J Surg Pathol; 2009 Jan; 33(1):81-90. PubMed ID: 18987541
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hyperplasia of hair follicles and other adnexal structures in cutaneous lymphoproliferative disorders: a study of 53 cases, including so-called pseudolymphomatous folliculitis and overt lymphomas.
    Kazakov DV; Belousova IE; Kacerovska D; Sima R; Vanecek T; Vazmitel M; Pizinger K; Michal M
    Am J Surg Pathol; 2008 Oct; 32(10):1468-78. PubMed ID: 18685486
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.